Multipotent bone marrow-derived stem cells regulatory update

FDA granted Fast Track designation for AlloCure's AC607 to treat acute kidney injury (AKI). The company plans to start Phase II testing of the formulation of allogeneic bone marrow-derived mesenechyma...